Your Testosterone Number Is Lying to You: Why Free vs. Total T Is the Difference Between Optimized and Overlooked

The surprising truth is your total testosterone can look fine. Yet your body may still feel low. Most labs stop at one number. They miss SHBG, which can trap testosterone.

Here is what this means for you. Test free T and SHBG with total T. If SHBG is high, less T reaches cells. If SHBG is low, total T can look low.

Use clear targets and timelines. Ask for morning labs, 7–10 AM. Recheck after 8–12 weeks of changes. On TRT, check hematocrit every 12 weeks first year.

For decades, endocrinologists have operated under the free hormone hypothesis: only unbound testosterone can enter cells and create biological effects. This assumption drives the clinical focus on measuring free testosterone rather than just total testosterone. However, recent research is challenging this fundamental principle [1].

The traditional model suggests that testosterone bound to SHBG is completely inactive, while testosterone bound to albumin can dissociate and become available to tissues. But emerging evidence indicates that SHBG-bound testosterone may have its own biological pathways, and that tissue-specific factors influence hormone uptake in ways that simple blood measurements can't capture.

This reappraisal doesn't invalidate free testosterone testing—it reveals why the same free testosterone level can produce different results in different people. Factors like tissue sensitivity, receptor density, and local enzyme activity create additional layers of variation that explain why some men feel optimal at free testosterone levels that leave others feeling subpar.

Testosterone doesn't work alone—it functions as a prohormone that converts to estradiol through the aromatase enzyme [2]. This conversion varies dramatically between individuals based on body composition, age, and genetic factors. Men with higher aromatase activity convert more testosterone to estradiol, potentially experiencing different effects from the same testosterone dose.

Body fat percentage particularly influences this conversion, as adipose tissue contains high levels of aromatase. This creates a metabolic feedback loop: men with obesity often show low total testosterone due to increased aromatization and SHBG suppression, but their free testosterone may remain adequate for normal function [3]. Standard reference ranges fail to account for these individual metabolic differences.

The result is that two men with identical lab values can have opposite treatment responses. One may build muscle and improve energy on testosterone replacement therapy, while another experiences minimal benefits or unwanted side effects like mood swings from excessive estradiol conversion.

Men with obesity present a unique challenge for testosterone interpretation. They frequently show low total testosterone that appears to indicate hypogonadism, but this reduction often represents functional suppression rather than true testicular failure [3]. Their lower SHBG levels mean that free testosterone may remain in the normal range despite suppressed total levels.

This distinction has profound therapeutic implications. True hypogonadism requires lifelong testosterone replacement, while obesity-related testosterone suppression may respond to weight loss and metabolic improvement. Treating functional suppression with testosterone therapy without addressing underlying metabolic issues can worsen insulin resistance and perpetuate the cycle.

The key diagnostic difference lies in the free testosterone and SHBG pattern. Men with obesity typically show low-normal free testosterone with suppressed SHBG, while men with organic hypogonadism show low free testosterone with normal or elevated SHBG. This pattern recognition changes the entire treatment approach.

Testosterone can affect your heart health in different ways. The delivery method matters. Oral testosterone goes through your liver first. That can shift blood fats in a bad direction.

A large meta-analysis of 36 RCTs (n=8,480) found oral testosterone increased LDL cholesterol [PMID: 31353194]. In contrast, another meta-analysis in intramuscular testosterone ester users found LDL fell by about 5 mg/dL (95% CI: −8 to −1) [PMID: 11566455]. These are not the same intervention.

TRT also raises red blood cells. A meta-analysis of 51 studies found hemoglobin rose by 0.80 g/dL (95% CI: 0.45 to 1.14) [PMID: 20525906]. This rise often shows up early in treatment. You need routine hemoglobin and hematocrit checks. High values can raise clot risk in some men.

Testosterone can increase lean mass. Meta-analyses show consistent gains. One meta-analysis of 29 RCTs (n=1,083) found fat-free mass rose by 1.6 kg. That is about a 2.7% increase from baseline (95% CI: 1.1% to 4.4%) [PMID: 16117815].

The men who gain most often start low. But lab numbers still do not predict results well. Free T changes usually track response better than total T.

Your results also depend on SHBG and aromatase. Higher SHBG can keep free T low at the same dose. Higher aromatase can raise estradiol at the same dose. Both can change how you feel and perform.

Total testosterone is only one clue. SHBG can hide what your tissues can use. Free and bioavailable testosterone better match real effects. If you have obesity, low total T may reflect low SHBG, not testis failure. If you use TRT, your delivery method and blood counts matter for safety. Test smart, then act on the full pattern.